Tag Archives: data

Eli Lilly’s Reyvow, squaring off against AbbVie and Biohaven, posts data showing early and lasting migraine relief

With several new acute migraine treatments vying for market share, Eli Lilly is touting new data on Reyvow showing the med can provide patients “pain freedom” in as little as one hour, plus sustained relief for up to two days. In a phase 3 trial called Centurion, patients who took Lilly’s new drug at the 200mg dose were 4.6 times more likely to experience pain… Read More »

Next Generation Data Centre, Newport named ‘Home of LINX Wales’ as new LINX PoP Goes LIVE

LINX Wales today announced it now has a fully functioning point of presence (PoP) at the NGD hyperscale data centre near Newport. This follows the previous announcement at the London Internet Exchange (LINX) member conference in London that Next Generation Data (NGD) – now part of Vantage Data Centers – was to become the home… Read More »

Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data

Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More »

ESC: Merck’s Steglatro shows limited promise with heart failure hospitalization data

Late to the party against its SGLT2 diabetes rivals, Merck & Co.’s Steglatro has also tracked way behind in the class’ growing presence in heart failure. Now, the drugmaker has posted new data showing Steglatro could, in fact, show benefits in that indication—but it’s a limited window into the future. Steglatro cut heart failure patients’ risk… Read More »